Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: Results of a nationwide cohort study from Taiwan

Journal of the American Academy of Dermatology

Volumn 69, Issue 1, 2013, Pages 25-33

  Chen, Yi Ju ^a,b   Wu, Chun Ying ^a,b,c   Shen, Jui Lung ^a   Chen, Tzu Ting ^b   Chang, Yun Ting ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

antipsoriatic drugs; association; psoriasis; traditional systemic; tuberculosis

Indexed keywords

ANTIPSORIASIS AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; ETRETIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HOSPITALIZATION; HUMAN; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUVA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SYSTEMIC THERAPY; TAIWAN; TUBERCULOSIS; ULTRAVIOLET B RADIATION;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; MALE; METHOTREXATE; MIDDLE AGED; ODDS RATIO; PSORIASIS; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; TUBERCULOSIS;

EID: 84879124959     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.12.966     Document Type: Article

References (40)

1. L.S. Tam, E.K. Li, S.M. Wong, and C.C. Szeto Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong Scand J Rheumatol 31 2002 296 300
2. M.Y. Mok, Y. Lo, T.M. Chan, W.S. Wong, and C.S. Lau Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy J Rheumatol 32 2005 609 615
3. L. Carmona, C. Hernandez-Garcia, C. Vadillo, E. Pato, A. Balsa, and I. Gonzalez-Alvaro Increased risk of tuberculosis in patients with rheumatoid arthritis J Rheumatol 30 2003 1436 1439
4. W.G. Dixon, K.L. Hyrich, K.D. Watson, M. Lunt, J. Galloway, and A. Ustianowski Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) Ann Rheum Dis 69 2010 522 528
5. R.S. Wallis, M.S. Broder, J.Y. Wong, M.E. Hanson, and D.O. Beenhouwer Granulomatous infectious diseases associated with tumor necrosis factor antagonists Clin Infect Dis 38 2004 1261 1265
6. J. Keane, S. Gershon, R.P. Wise, E. Mirabile-Levens, J. Kasznica, and W.D. Schwieterman Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 2001 1098 1104
7. A.K. Mohan, T.R. Cote, J.A. Block, A.M. Manadan, J.N. Siegel, and M.M. Braun Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor Clin Infect Dis 39 2004 295 299
8. J.J. Gomez-Reino, L. Carmona, V.R. Valverde, E.M. Mola, and M.D. Montero Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report Arthritis Rheum 48 2003 2122 2127
9. P.A. Jensen, L.A. Lambert, M.F. Iademarco, and R. Ridzon Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005 MMWR Recomm Rep 54 2005 1 141
10. S.D. Doherty, A. Van Voorhees, M.G. Lebwohl, N.J. Korman, M.S. Young, and S. Hsu National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents J Am Acad Dermatol 59 2008 209 217
11. C.H. Smith, A.V. Anstey, J.N. Barker, A.D. Burden, R.J. Chalmers, and D.A. Chandler British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009 Br J Dermatol 161 2009 987 1019
12. D.Y. Chen, G.H. Shen, T.Y. Hsieh, C.W. Hsieh, and J.L. Lan Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy Arthritis Rheum 59 2008 800 806
13. Y.T. Chang, T.J. Chen, P.C. Liu, Y.C. Chen, Y.J. Chen, and Y.L. Huang Epidemiological study of psoriasis in the national health insurance database in Taiwan Acta Derm Venereol 89 2009 262 266
14. Y.J. Chen, Y.T. Chang, J.L. Shen, T.T. Chen, C.B. Wang, and C.M. Chen Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study Arthritis Rheum 64 2012 1879 1887
15. C.Y. Wu, M.S. Wu, K.N. Kuo, C.B. Wang, Y.J. Chen, and J.T. Lin Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients J Clin Oncol 28 2010 2952 2957
16. C.Y. Wu, K.N. Kuo, M.S. Wu, Y.J. Chen, C.B. Wang, and J.T. Lin Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease Gastroenterology 137 2009 1641 1648.e1-2
17. C.L. Cheng, Y.H. Kao, S.J. Lin, C.H. Lee, and M.L. Lai Validation of the national health insurance research database with ischemic stroke cases in Taiwan Pharmacoepidemiol Drug Saf 20 2011 236 242
18. C.C. Lin, M.S. Lai, C.Y. Syu, S.C. Chang, and F.Y. Tseng Accuracy of diabetes diagnosis in health insurance claims data in Taiwan J Formos Med Assoc 104 2005 157 163
19. J.M. Gelfand, A.L. Neimann, D.B. Shin, X. Wang, D.J. Margolis, and A.B. Troxel Risk of myocardial infarction in patients with psoriasis JAMA 296 2006 1735 1741
20. N.N. Mehta, R.S. Azfar, D.B. Shin, A.L. Neimann, A.B. Troxel, and J.M. Gelfand Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database Eur Heart J 31 2010 1000 1006
21. P. Brassard, A. Kezouh, and S. Suissa Antirheumatic drugs and the risk of tuberculosis Clin Infect Dis 43 2006 717 722
22. P. Brassard, A.M. Lowe, S. Bernatsky, A. Kezouh, and S. Suissa Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada Arthritis Rheum 61 2009 300 304
23. V. Essebag, R.W. Platt, M. Abrahamowicz, and L. Pilote Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure BMC Med Res Methodol 5 2005 5
24. V. Essebag, J. Genest Jr., S. Suissa, and L. Pilote The nested case-control study in cardiology Am Heart J 146 2003 581 590
25. H.C. Lin, Y.J. Lin, T.C. Liu, C.S. Chen, and W.T. Chiu Urbanization and stroke prevalence in Taiwan: analysis of a nationwide survey J Urban Health 84 2007 604 614
26. H.Y. Lo, P. Chou, S.L. Yang, C.Y. Lee, and H.S. Kuo Trends in tuberculosis in Taiwan, 2002-2008 J Formos Med Assoc 110 2011 501 510
27. C.L. Hou, Y.C. Tsai, L.C. Chen, and J.L. Huang Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared Clin Rheumatol 27 2008 557 563
28. R. Gonzalez Leon, R. Garrido Rasco, E. Chinchilla Palomares, F.J. Garcia Hernandez, M.J. Castillo Palma, and J. Sanchez Roman Tuberculosis in a cohort of patients with systemic lupus erythematosus Rheumatol Clin 6 2010 256 261
29. K.P. Hunfeld, M. Rittmeister, T.A. Wichelhaus, V. Brade, and R. Enzensberger Two cases of chronic arthritis of the forearm due to Mycobacterium tuberculosis Eur J Clin Microbiol Infect Dis 17 1998 344 348
30. M.J. Al-Sayyad, and L.A. Abumunaser Tuberculous arthritis revisited as a forgotten cause of monoarticular arthritis Ann Saudi Med 31 2011 398 401
31. A. Ocguder, O. Tosun, O. Akkurt, T. Oguz, and T. Colakoglu Tuberculosis of the foot: a rare involvement in osteoarticular tuberculosis J Clin Rheumatol 12 2006 304 305
32. V. Bordignon, S. Bultrini, G. Prignano, I. Sperduti, G. Piperno, and C. Bonifati High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer J Biol Regul Homeost Agents 25 2011 213 220
33. L.C. Silva, G.G. Silveira, M. Arnone, R. Romiti, A. Geluk, and K.C. Franken Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area Arch Dermatol Res 302 2010 255 262
34. J.D. Smith, and J.M. Knox Psoriasis, methotrexate and tuberculosis Br J Dermatol 84 1971 590 593
35. K. Binymin, and R.G. Cooper Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis Rheumatology (Oxford) 40 2001 341 342
36. C. di Girolamo, N. Pappone, E. Melillo, C. Rengo, F. Giuliano, and G. Melillo Cavitary lung tuberculosis in a rheumatoid arthritis patient treated with low-dose methotrexate and steroid pulse therapy Br J Rheumatol 37 1998 1136 1137
37. D.H. Solomon The comparative safety and effectiveness of TNF-alpha antagonists J Manag Care Pharm 13 Suppl 2007 S7 S18
38. C. Vadillo Font, C. Hernandez-Garcia, E. Pato, I.C. Morado, M. Salido, and E. Judez Incidence and characteristics of tuberculosis in patients with autoimmune rheumatic diseases [in Spanish] Rev Clin Esp 203 2003 178 182
39. T.J. Vachharajani, U.G. Oza, A.G. Phadke, and A.L. Kirpalani Tuberculosis in renal transplant recipients: rifampicin sparing treatment protocol Int Urol Nephrol 34 2002 551 553
40. S.M. Behnam, S.E. Behnam, and J.Y. Koo Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use J Drugs Dermatol 4 2005 189 194